EXACT Balance Sheet Analysis From 2010 to 2024

EXAS Stock

USD 62.41 1.45 2.38%

Most indicators from EXACT Sciences' financial ratios are interrelated and interconnected. However, analyzing financial ratios indicators one by one will only give a small insight into EXACT Sciences current financial condition. On the other hand, looking into the entire matrix of financial ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out EXACT Sciences Valuation and EXACT Sciences Correlation analysis.

For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.

At this time, EXACT Sciences' Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 2.5 M in 2024, despite the fact that Enterprise Value Over EBITDA is likely to grow to (1.1 K).

Most indicators from EXACT Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into EXACT Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out EXACT Sciences Valuation and EXACT Sciences Correlation analysis.

For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.At this time, EXACT Sciences' Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 2.5 M in 2024, despite the fact that Enterprise Value Over EBITDA is likely to grow to (1.1 K).

	2021	2022	2023	2024 (projected)
Non Recurring	20.2M	16.0M	14.4M	13.7M
Reconciled Depreciation	180.3M	197.6M	206.6M	131.5M

Non Recurring Reconciled Depreciation

EXACT Sciences fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Cash	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Common Stock Total Equity	Other Current Assets	Property Plant And Equipment Gross	Common Stock	Intangible Assets	Property Plant Equipment	Good Will	Other Liab	Short Term Investments
Total Assets		0.99	0.9	0.64	0.9	0.65	0.89	0.99	0.99	0.79	0.47	0.97	0.99	-0.97	0.97	0.99	-0.91	0.9	0.97	0.96	0.88	0.98	0.99	0.99	0.91	0.29
Total Stockholder Equity	0.99		0.86	0.67	0.91	0.67	0.9	0.99	0.97	0.8	0.45	0.97	0.99	-0.94	0.94	0.97	-0.87	0.9	0.95	0.94	0.89	0.96	0.98	0.97	0.86	0.27
Net Debt	0.9	0.86		0.27	0.7	0.36	0.79	0.9	0.93	0.52	0.54	0.78	0.91	-0.92	0.95	0.94	-0.88	0.79	0.96	0.9	0.77	0.95	0.93	0.94	0.96	0.3
Cash	0.64	0.67	0.27		0.75	0.86	0.58	0.64	0.6	0.87	0.12	0.8	0.61	-0.58	0.52	0.54	-0.49	0.59	0.5	0.59	0.59	0.49	0.58	0.54	0.38	0.14
Other Assets	0.9	0.91	0.7	0.75		0.76	0.75	0.87	0.88	0.85	0.32	0.94	0.85	-0.81	0.8	0.86	-0.87	0.73	0.8	0.78	0.74	0.85	0.86	0.86	0.78	0.32
Cash And Short Term Investments	0.65	0.67	0.36	0.86	0.76		0.69	0.65	0.63	0.98	0.17	0.78	0.61	-0.61	0.58	0.52	-0.54	0.66	0.52	0.54	0.69	0.48	0.61	0.52	0.41	0.62
Common Stock Shares Outstanding	0.89	0.9	0.79	0.58	0.75	0.69		0.92	0.88	0.8	0.41	0.87	0.9	-0.92	0.89	0.86	-0.77	0.99	0.89	0.87	1.0	0.84	0.9	0.85	0.79	0.46
Other Stockholder Equity	0.99	0.99	0.9	0.64	0.87	0.65	0.92		0.99	0.78	0.48	0.96	0.99	-0.98	0.97	0.98	-0.9	0.93	0.98	0.97	0.91	0.97	0.99	0.98	0.91	0.28
Total Liab	0.99	0.97	0.93	0.6	0.88	0.63	0.88	0.99		0.77	0.49	0.96	0.98	-0.98	0.98	0.98	-0.93	0.88	0.98	0.96	0.86	0.97	0.99	0.98	0.94	0.31
Total Current Assets	0.79	0.8	0.52	0.87	0.85	0.98	0.8	0.78	0.77		0.25	0.89	0.76	-0.74	0.72	0.68	-0.67	0.77	0.68	0.7	0.79	0.65	0.75	0.68	0.57	0.57
Other Current Liab	0.47	0.45	0.54	0.12	0.32	0.17	0.41	0.48	0.49	0.25		0.37	0.5	-0.52	0.5	0.5	-0.62	0.36	0.45	0.37	0.4	0.5	0.43	0.5	0.45	0.15
Total Current Liabilities	0.97	0.97	0.78	0.8	0.94	0.78	0.87	0.96	0.96	0.89	0.37		0.95	-0.92	0.91	0.93	-0.86	0.87	0.91	0.92	0.86	0.9	0.95	0.93	0.83	0.3
Property Plant And Equipment Net	0.99	0.99	0.91	0.61	0.85	0.61	0.9	0.99	0.98	0.76	0.5	0.95		-0.96	0.96	0.98	-0.86	0.9	0.98	0.97	0.89	0.97	0.99	0.98	0.89	0.28
Retained Earnings	-0.97	-0.94	-0.92	-0.58	-0.81	-0.61	-0.92	-0.98	-0.98	-0.74	-0.52	-0.92	-0.96		-0.98	-0.96	0.9	-0.92	-0.97	-0.96	-0.9	-0.94	-0.96	-0.96	-0.93	-0.29
Accounts Payable	0.97	0.94	0.95	0.52	0.8	0.58	0.89	0.97	0.98	0.72	0.5	0.91	0.96	-0.98		0.97	-0.9	0.89	0.99	0.96	0.87	0.96	0.98	0.96	0.95	0.34
Non Current Assets Total	0.99	0.97	0.94	0.54	0.86	0.52	0.86	0.98	0.98	0.68	0.5	0.93	0.98	-0.96	0.97		-0.91	0.87	0.99	0.96	0.85	1.0	0.99	1.0	0.94	0.2
Non Currrent Assets Other	-0.91	-0.87	-0.88	-0.49	-0.87	-0.54	-0.77	-0.9	-0.93	-0.67	-0.62	-0.86	-0.86	0.9	-0.9	-0.91		-0.74	-0.88	-0.8	-0.74	-0.91	-0.88	-0.92	-0.93	-0.32
Common Stock Total Equity	0.9	0.9	0.79	0.59	0.73	0.66	0.99	0.93	0.88	0.77	0.36	0.87	0.9	-0.92	0.89	0.87	-0.74		0.9	0.9	0.99	0.85	0.91	0.86	0.79	0.38
Other Current Assets	0.97	0.95	0.96	0.5	0.8	0.52	0.89	0.98	0.98	0.68	0.45	0.91	0.98	-0.97	0.99	0.99	-0.88	0.9		0.98	0.87	0.98	0.99	0.98	0.95	0.26
Property Plant And Equipment Gross	0.96	0.94	0.9	0.59	0.78	0.54	0.87	0.97	0.96	0.7	0.37	0.92	0.97	-0.96	0.96	0.96	-0.8	0.9	0.98		0.85	0.94	0.97	0.96	0.9	0.17
Common Stock	0.88	0.89	0.77	0.59	0.74	0.69	1.0	0.91	0.86	0.79	0.4	0.86	0.89	-0.9	0.87	0.85	-0.74	0.99	0.87	0.85		0.83	0.89	0.84	0.75	0.44
Intangible Assets	0.98	0.96	0.95	0.49	0.85	0.48	0.84	0.97	0.97	0.65	0.5	0.9	0.97	-0.94	0.96	1.0	-0.91	0.85	0.98	0.94	0.83		0.98	1.0	0.94	0.2
Property Plant Equipment	0.99	0.98	0.93	0.58	0.86	0.61	0.9	0.99	0.99	0.75	0.43	0.95	0.99	-0.96	0.98	0.99	-0.88	0.91	0.99	0.97	0.89	0.98		0.98	0.92	0.31
Good Will	0.99	0.97	0.94	0.54	0.86	0.52	0.85	0.98	0.98	0.68	0.5	0.93	0.98	-0.96	0.96	1.0	-0.92	0.86	0.98	0.96	0.84	1.0	0.98		0.95	0.18
Other Liab	0.91	0.86	0.96	0.38	0.78	0.41	0.79	0.91	0.94	0.57	0.45	0.83	0.89	-0.93	0.95	0.94	-0.93	0.79	0.95	0.9	0.75	0.94	0.92	0.95		0.23
Short Term Investments	0.29	0.27	0.3	0.14	0.32	0.62	0.46	0.28	0.31	0.57	0.15	0.3	0.28	-0.29	0.34	0.2	-0.32	0.38	0.26	0.17	0.44	0.2	0.31	0.18	0.23

Click cells to compare fundamentals

EXACT Sciences Account Relationship Matchups

EXACT Sciences fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.5B	4.9B	6.7B	6.2B	6.5B	6.8B
Net Debt	769.0M	(27.1M)	2.0B	2.2B	1.9B	2.0B
Cash	177.3M	1.5B	315.5M	242.5M	605.4M	635.6M
Other Assets	20.3M	63.8M	74.6M	36.7M	42.2M	44.3M
Total Liab	1.2B	2.1B	3.3B	3.2B	3.3B	3.5B
Total Current Assets	557.0M	2.2B	1.4B	982.3M	1.2B	1.3B
Other Current Liab	8.5M	38.3M	31.0M	306.4M	14.8M	20.2M
Retained Earnings	(1.1B)	(2.0B)	(2.6B)	(3.3B)	(3.5B)	(3.3B)
Accounts Payable	26.0M	35.7M	67.8M	74.9M	78.8M	82.8M
Other Current Assets	40.9M	33.2M	74.1M	73.9M	85.6M	89.9M
Common Stock	1.5M	1.6M	1.7M	1.8M	1.8M	1.9M
Intangible Assets	1.1B	848.4M	2.1B	2.0B	1.9B	2.0B
Good Will	1.2B	1.2B	2.3B	2.3B	2.4B	2.5B
Other Liab	28.1M	61.6M	417.8M	345.1M	396.8M	416.7M
Long Term Debt	827.6M	1.3B	2.2B	2.2B	2.3B	2.4B
Net Tangible Assets	(58.7M)	737.4M	(1.0B)	697.1M	627.4M	658.8M
Long Term Debt Total	4.3M	688.8M	827.6M	2.2B	2.5B	2.6B
Capital Surpluse	3.4B	4.8B	6.0B	6.3B	7.3B	7.6B
Inventory	61.7M	92.3M	105.0M	118.3M	127.5M	133.8M
Short Term Debt	8.7M	268.3M	19.7M	28.4M	79.4M	83.3M

Pair Trading with EXACT Sciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EXACT Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EXACT Sciences will appreciate offsetting losses from the drop in the long position's value.

Moving against EXACT Stock

0.67	EGRX	Eagle Pharmaceuticals	Pair Corr
0.62	PCVX	VaxcyteInc Financial Report 13th of May 2024	Pair Corr
0.61	REPL	Replimune Group Financial Report 16th of May 2024	Pair Corr
0.58	ANAB	AnaptysBio Financial Report 9th of May 2024	Pair Corr
0.53	GNTA	Genenta Science SpA Report 24th of April 2024	Pair Corr

The ability to find closely correlated positions to EXACT Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EXACT Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EXACT Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EXACT Sciences to buy it.

The correlation of EXACT Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EXACT Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EXACT Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for EXACT Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether EXACT Sciences is a strong investment it is important to analyze EXACT Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EXACT Sciences' future performance. For an informed investment choice regarding EXACT Stock, refer to the following important reports:

How To Invest In EXACT

Details

Is EXACT Stock a good investment?

Details

What is EXACT Sciences' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out EXACT Sciences Valuation and EXACT Sciences Correlation analysis.

For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.

Note that the EXACT Sciences information on this page should be used as a complementary analysis to other EXACT Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for EXACT Stock analysis

When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.

	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum

Is EXACT Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EXACT Sciences. If investors know EXACT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.13)

Revenue Per Share

13.876

Quarterly Revenue Growth

0.17

Return On Assets

(0.03)

Return On Equity

(0.07)

The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between EXACT Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if EXACT Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EXACT Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

EXACT Balance Sheet Analysis From 2010 to 2024

EXACT Sciences fundamental ratios Correlations

EXACT Sciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

EXACT Sciences fundamental ratios Accounts

Pair Trading with EXACT Sciences

Moving against EXACT Stock

Complementary Tools for EXACT Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Shares Outstanding
Intangible Assets	+ 1.0	Non Current Assets Total
Good Will	+ 1.0	Non Current Assets Total
Good Will	+ 1.0	Intangible Assets
Total Stockholder Equity	+ 0.99	Total Assets
Other Stockholder Equity	+ 0.99	Total Assets

Accounts Payable	- 0.98	Retained Earnings
Retained Earnings	- 0.98	Total Liab
Retained Earnings	- 0.98	Other Stockholder Equity
Other Current Assets	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Total Assets
Good Will	- 0.96	Retained Earnings